BioPharmSignal logoBioPharmSignal

Biotech News

Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference

Kiniksa (KNSA)KiniksaConference / presentation

LONDON, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the Canaccord Genuity 46 th Annual Growth Conference on Wednesday, August 12, 2026 at 9:00 a.m. Eastern Time.

Related news

KNSAKiniksa2026-05-29 20:01 EST

Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences

ENTAEnanta Pharmaceuticals2026-05-28 11:00 EST

Enanta Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

XFORX4 Pharmaceuticals2026-05-27 11:00 EST

X4 Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference

KNSAKiniksa2026-07-23 20:01 EST

Kiniksa Pharmaceuticals to Report Second Quarter 2026 Financial Results on July 28, 2026

XGNExagen2026-07-28 13:00 EST

Exagen Inc. to Participate in Upcoming Investor Conference

AVTXAvalo Therapeutics2026-07-22 11:00 EST

Avalo Therapeutics to Participate in the BTIG Biotechnology Conference

KYMRKymera2026-05-27 11:00 EST

Kymera Therapeutics to Participate in Fireside Chat at the Jefferies Global Healthcare Conference

TLSATiziana Life Sciences2026-05-28 11:00 EST

Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference in New York

CUECue Biopharma Inc2026-05-21 20:05 EST

Cue Biopharma to Present at the 2026 Jefferies Global Healthcare Conference

EQEquillium, Inc.2026-05-28 20:05 EST

Equillium to Participate in the 2026 Jefferies Global Healthcare Conference

View all latest news

Kiniksa

IL-1 Cardiovascular Franchise Kiniksa Pharmaceuticals develops and commercializes therapies for diseases with strong biological rationale, with an emphasis on cardiovascular inflammation. Its portfolio is centered on blocking interleukin-1 alpha and beta signaling. ARCALYST ARCALYST, or rilonacept, is a weekly subcutaneous IL-1 cytokine...

Recent company news

KNSAKiniksa2026-08-07 20:01 EST

Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference

KNSAKiniksa2026-07-28 11:30 EST

Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution

KNSAKiniksa2026-07-23 20:01 EST

Kiniksa Pharmaceuticals to Report Second Quarter 2026 Financial Results on July 28, 2026

KNSAKiniksa2026-05-29 20:01 EST

Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences

KNSAKiniksa2026-04-28 11:30 EST

Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution

Stock data

Close
76.51 USD
Market cap
3.61B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States